[{"data":1,"prerenderedAt":26},["ShallowReactive",2],{"project-b40d329969ef5fea00daa19b5e167194":3},{"_id":4,"slug":4,"title":5,"subtitle":6,"cover":8,"tech_type":9,"indications":10,"official_price":11,"hospital_name":12,"hospital_names":13,"tech_company_name":12,"view_count":14,"favorite_count":15,"is_favorite":16,"approval_no":17,"approval_date":18,"regulatory_level":19,"valid_until":18,"filing_date":20,"intro":21,"detail_desc":22,"target_population":23,"compliance_list":24,"process":25},"b40d329969ef5fea00daa19b5e167194","类风湿关节炎的人脐带间充质干细胞应用技术",[7],"类风湿关节炎","https://6875-huali-cell-8geyb3yje6a285d1-1419749029.tcb.qcloud.la/assets/covers/cover-05.jpg","干细胞应用",[7],"5万元/次*4次/人=20万","北京贝来生物科技有限公司",[],221,1,false,"乐城第四批获批","","低风险","2025年","\u003Cp>人脐带间充质生物医学新技术静脉回输,免疫调节用于难治性类风湿关节炎。\u003C/p>\u003Cp>\u003Cb>适应症\u003C/b>:类风湿关节炎(RA)\u003Cbr>\u003Cb>技术类型\u003C/b>:生物医学新技术\u003Cbr>\u003Cb>批次\u003C/b>:乐城第四批获批\u003C/p>","人脐带间充质干细胞静脉回输,免疫调节用于难治性类风湿关节炎。",[],[],[],1779368115444]